Healthcare Realty Trust Announces Third Quart... ( NASHVILLE Tenn. Nov. 10 /- Health...)

Healthcare Realty Trust Announces Third Quarter Results

Date:11/10/2008

NASHVILLE, Tenn., Nov. 10 /PRNewswire-FirstCall/ -- Healthcare Realty Trust Incorporated (NYSE: HR) today announced results for the third quarter ended September 30, 2008. Funds from operations ("FFO") per diluted common share totaled $0.36, compared with $0.31 for the same period in 2007. FFO per diluted common share totaled $1.13 for the nine months ended September 30, 2008, compared with the prior year's $1.13. FFO would have been $0.38 and $1.14 per diluted common share for the three and nine months ended September 30, 2008, respectively, before a one-time charge of $765,000 related to a litigation expense settlement. Funds available for distribution ("FAD") for the third quarter of 2008 totaled $0.44 per diluted common share.

Revenues for the three months ended September 30, 2008 totaled $54.8 million, compared with the prior year's $50.5 million. Revenues for the nine months ended September 30, 2008 totaled $159.8 million, compared with the prior year's $149.7 million. Income from continuing operations for the three months ended September 30, 2008 totaled $3.3 million, compared with $4.0 million for the three months ended September 30, 2007. Income from continuing operations for the nine months ended September 30, 2008 totaled $12.5 million, compared with the prior year's $9.3 million.

Net income for the third quarter of 2008 totaled $5.5 million, or $0.11 per diluted common share, versus $5.5 million, or $0.12 per diluted common share, for the third quarter of 2007. Net income for the nine months ended September 30, 2008 totaled $26.1 million, or $0.52 per diluted common share, compared with $55.5 million, or $1.17 per diluted common share for the nine months ended September 30, 2007. Net income for the nine months ende
'/>"/>

SOURCE Healthcare Realty Trust Incorporated
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9
Related medicine news :

1. World Publics See Government as Responsible for Ensuring Basic Healthcare, Food, and Education Needs
2. MAP Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
3. Wyeth to Present at the Credit Suisse Healthcare Conference
4. Velocity Emerges as Healthcare Technology Leader
5. Ford Motor Co. Tops First-Ever Healthcare Purchasing Power Survey
6. Quest Diagnostics to Speak at the 2008 Credit Suisse Healthcare Conference
7. Axway and Edifecs Form Strategic Partnership to Benefit Healthcare Payors
8. Live Event and Webcast: Blue Cross and Blue Shield Association Spearheads Major Initiative to Improve Healthcare Quality, Increase Cost Efficiency
9. Zimmer Holdings to Present at Credit Suisse 2008 Healthcare Conference
10. Chief Executive Officer Leaving Integrated Healthcare Holdings, Inc.
11. Allied Healthcare Net Income Increases

Post Your Comments:

(Date:11/9/2009)..., ROCHESTER, Minn., Nov. 9 /PRNewswire-USNewswire...ic surgery for vaginal prolapse dramatically r...ese findings are being presented this week at the ...ssociation in Scottsdale, Ariz. ,, (Logo: ht...O ) ,, VIDEO ALERT : Additional audio and vi...

(Date:11/9/2009)..., Vote shows the need to transform our current c...PRNewswire-USNewswire/ -- Members of Congress who ...Saturday night have received $2.3 million more in ... than those who voted in favor of the legislation ...cording to analysis released by a coalition of cam...

(Date:11/9/2009)...t. Jude Children,s Research Hospital and the Unive...med a collaboration to provide proton therapy for ...proval of the first clinical study to evaluate the...hildren younger than 3 years old. , Under the ... receive proton therapy at the UF Proton Therapy I...

(Date:11/9/2009)... Blacksburg, Va. In the construction industry, re...an increased risk of cancer, is a major public hea..., a faculty member in Virginia Tech,s School of Co...ing tools are highly effective in reducing the dus...ry,s usage of the available technology remains ver...

(Date:11/9/2009)...CCRA, Ghana -- The lives of almost 4 million women...ld be saved every year if well-established, afford...of families, according to a joint report by the na...s. Many African nations are underutilizing existi...port, which calls on scientists, health care provi...

Breaking Medicine News(10 mins):Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 2 Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 3 Health News:'No' Votes on Health Care Bill Received $2.3 Million More from Health Insurance Industry 2 Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2 Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 2 Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 3 Health News:Using science to save lives of mothers and children in Africa 2 Health News:Using science to save lives of mothers and children in Africa 3 Health News:Using science to save lives of mothers and children in Africa 4

[0] Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits [0] 'No' Votes on Health Care Bill Received $2.3 Million More from Health Insurance Industry [0] St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial [0] Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls [0] Using science to save lives of mothers and children in Africa

...ct via automated system proves beneficial in study... automated calling system helps people with hypert...or fatal consequences of their condition and helps...portable monitors that took 24-hour blood pressure...

....S. officials say there,s no longer a need to clos... 5 (HealthDay News) -- A Texas woman who lived al...problems died this week after contracting swine fl...ath of a Texas resident with H1N1 flu," state heal...

...crisis, epicenter, Mexico, may also be getting bac...ay 5 (HealthDay News) -- U.S. health officials on ...u appears similar to the seasonal flu in its sever...m the previous guidance, which recommended affecte...

... Northshore Chicago plastic surgeon ...etic Surgery Education and Research Foundation (AS...us) May 5, 2009 -- Northshore Chicago plastic surg...ty and effectiveness of new aesthetic (cosmetic) p...

... May 5 ResMed Inc. (NYSE: RMD ) announced today...care conferences. Kieran Gallahue, President and C... Lynch Health Care Conference at the New York Pala... at the Deutsche Bank Health Care Conference on Ma...

...ay 5 Saints Mary and Elizabeth Medical Center, 22...f its Community Health Education Department, recei... of the Susan G. Komen for the Cure(R) to support ... otherwise be able to afford mammograms have recei...

Phone Monitoring May Help Lower Blood Pressure Texas Officials Report 2nd Swine Flu Death in U.S.Swine Flu Appears Mild And Schools Should Stay Open, U.S. Officials Say Northshore Chicago Plastic Surgeon is the First Female President of the Aesthetic Surgery Education and Research Foundation (ASERF) ResMed Inc. to Present at Upcoming Healthcare Conferences in May Susan G. Komen Funds Mammograms for Saints Mary and Elizabeth Medical Center

(Date:11/9/2009)...VILLE, Md., Nov. 9 OriGene Technol...hnology in Sweden has adopted its VERIFY Tagged An...rotein Atlas program. This program is funded by th...up to explore the human proteome systematically us...ality mono-specific antibodies in a high throughpu...

(Date:11/9/2009)...LOUIS, Nov. 9, 2009 Mons...PFE ) today announced that they have entered into ...terfield Village Research Center located in Cheste...santo will acquire the property from Pfizer for $4...ontinue to have operations at Chesterfield Village...

(Date:11/9/2009)...INIA BEACH, Va., Nov. 9 LifeNet He...ounces the launch of Vertigraft Cervical Bio-Impla...eservon® is a new, proprietary glycerol-based...mplants to be stored in a fully hydrated state at ...reeze or freeze-dry bio-implants, doing away with ...

Breaking Medicine Technology:Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program 2 Monsanto to Purchase Chesterfield Village Research Center From Pfizer 2 Monsanto to Purchase Chesterfield Village Research Center From Pfizer 3 LifeNet Health Announces First Bio-Implant with New Preservation Technology 2 New Scientific Evidence Suggests Humans Resistant to Phthalate Effect on Lab Rodents 50095 1 New Scientific Evidence Suggests Humans Resistant to Phthalate Effect on Lab Rodents 50095 2 10 students receive scholarships for outstanding work in public health systems research 50092 1 Glucose challenge test is accurate and economical for diabetes and prediabetes screening 50089 1 Glucose challenge test is accurate and economical for diabetes and prediabetes screening 50089 2 Glucose challenge test is accurate and economical for diabetes and prediabetes screening 50089 3

[0] Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program [0] Monsanto to Purchase Chesterfield Village Research Center From Pfizer [0] LifeNet Health Announces First Bio-Implant with New Preservation Technology

...tor,Pharmaceuticals Corp. ("Raptor" or the "Compan...at the Company has entered into an agreement with,...U d,Angers") of France to,evaluate Raptor,s propri...ysteamine") in a Phase II clinical trial in patien... d,Angers has received a grant from the,Programme ...

...ety and Improvement in Heart Failure in a ...S, Nov. 9 Celladon Corporation announced,today re...DICAR(R), a,genetically-targeted enzyme replacemen...roduct was safe and demonstrating improvement acro...he "Calcium Up-Regulation by,Percutaneous Administ...

Other Medicine Technology:Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 2 Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 3 Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 4 Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 5 Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 6 Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions 2 Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions 3 Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions 4

Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease Celladon Announces Presentation of Clinical Data From First-in-Human MYDICAR(R) Trial for Advanced Heart Failure at American Heart Association Scientific Sessions

...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...

Medicine Products:

F-Actin (Smooth Muscle) Antibody, IgG by ELISA with Reflex to Smooth Muscle Antibody, IgG Titer F (fluoride), Urine Eye Culture Extractable Nuclear Antigen Antibodies (RNP, Smith, Scleroderma, SSA, & SSB)

Healthcare Realty Trust Announces Third Quart...( NASHVILLE Tenn. Nov. 10 /- Health...),Health